Innorna is a platform-based biotechnology company focused on the research and development of delivery systems for nucleic acid therapeutics. Founded in 2019, the company possesses globally leading, proprietary LNP (Lipid Nanoparticle) delivery technology with comprehensive patent coverage worldwide. Through collaborations and licensing agreements with numerous domestic and international biopharmaceutical companies, Innorna enables partners to leverage its advanced LNP platform to develop innovative nucleic acid-based drugs targeting various disease areas including rare diseases, infectious diseases, and oncology, with several pipelines already advancing to clinical trial stages.

For Innorna's global digital presence, we delivered comprehensive branding and web solutions. Our services included the development of a complete Brand VI system that communicates scientific precision and innovation, the design and implementation of an internationally-minded, minimalist website with fully responsive H5 technology, strategic UX prototyping to effectively present complex technological and partnership information, sophisticated visual design that reflects their position as industry pioneers, and complete front-end production with robust back-end development. We managed seamless server deployment and code migration for their international domain (www.innorna.com), ensuring optimal performance and accessibility for their global partners and stakeholders.